1-4 of 4
Angelo M. Carella, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Craig H. Moskowitz, MD, Auayporn Nadamanee, MD, Tamas Masszi, MD PhD, Edward Agura, MD, Jerzy Holowiecki, MD PhD, Muneer H. Abidi, MD, Andy I Chen, MDPhD, Patrick J. Stiff, MD, Alessandro M. Gianni, MD, Angelo M. Carella, MD, Dzhelil Osmanov, MD, Veronika Bachanova, MD, John Sweetenham, MD, Anna Sureda, Dirk Huebner, MD, Emily K. Larsen, MS, Naomi N.H. Hunder, MD, Jan Walewski
Journal: Blood
Blood (2014) 124 (21): 673.
https://doi.org/10.1182/blood.V124.21.673.673
Published: 2014
Journal Articles

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Emilio Iannitto, MD, Stefano Luminari, MD, Caterina Mammi, MD, Viviana Minardi, Francesco Merli, MD, Francesco Angrilli, MD, Caterina Stelitano, MD, Marina Cesaretti, Giovanni Franco, MD, Angelo M. Carella, MD, Massimo Federico, MD
Journal: Blood
Blood (2007) 110 (11): 1293.
https://doi.org/10.1182/blood.V110.11.1293.1293
Published: 2007
Journal Articles

Autologous Stem Cell Transplantation Followed by Reduced Intensity Allogeneic Stem Cell Transplantation (Tandem Transplantation) as Treatment for Advanced Resistant Hodgkin’s Lymphoma Patients. A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Ivan Alvarez, MD, Carme Canals, MD, Goli Taghipour, Angelo M. Carella, MD, PhD, Yves Beguin, MD, PhD, Didier Blaise, MD, PhD, Danielle Lazzlo, MD, PhD, Bernardino Aillone, MD, PhD, Jean H. Bourhis, MD, PhD, Lucca Castagna, MD, PhD, Paolo Corradini, MD, PhD, Paolo Iacopino, MD, PhD, Giuseppe Milone, MD, PhD, Pedro Pimentel, MD, PhD, Nigel H. Russell, MD, PhD, Pierre Zachee, MD, PhD, Anna Sureda, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3044.
https://doi.org/10.1182/blood.V108.11.3044.3044
Published: 2006
Journal Articles

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial.

Monica Bocchia, MD, Elisabetta Abruzzese, MD, Micaela Ippoliti, PhD, Maria Teresa Pirrotta, MD, Malgorzata M. Trawinska, MD, Marilina Amabile, PhD, Giovanni Martinelli, MD, Francesco Forconi, MD, Alessandro Gozzetti, MD, Angelo M. Carella, MD, Donatella Raspadori, PhD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 167.
https://doi.org/10.1182/blood.V106.11.167.167
Published: 2005